compounded glp 1 fda GLP-1 Safety Check FDA says that the GLP-1
Description
Updated June 1, 2025

Diabetes Obes Metab 21: 13111321

Zepbound is the same molecule (tirzepatide) approved for obesity

The modest effects likely insufficient for substantial weight loss requiring more aggressive approaches

Therefore, direct protection of cardiovascular system and favorable effects on multiple cardiovascular risk factors (hyperglycemia, blood pressure, dyslipidemia, body weight) observed in patients receiving GLP-1RAs may provide an explanation for the cardiovascular benefits of GLP-1RAs (Fig

Some patients alternate between periods of active medication and monitoring phases, while others find continuous therapy more practical
